Codexis, Inc. (CDXS)
1.60
-0.07
(-4.19%)
USD |
NASDAQ |
Mar 20, 16:00
1.595
0.00 (0.00%)
After-Hours: 20:00
Codexis EPS Diluted (Quarterly) : 0.1056 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Incyte Corp. | 1.462 |
| Viridian Therapeutics, Inc. | -1.080 |
| Lunai Bioworks, Inc. | -0.0766 |
| Beam Therapeutics, Inc. | 2.328 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 9.601M |
| Revenue (Quarterly) | 38.92M |
| Total Expenses (Quarterly) | 29.31M |
| Enterprise Value | 139.91M |
| Gross Profit Margin (Quarterly) | 91.36% |
| Profit Margin (Quarterly) | 24.67% |
| Earnings Yield | -32.38% |
| Normalized Earnings Yield | -30.75 |